COMMUNIQUÉS West-GlobeNewswire

Apellis Pharmaceuticals Announces Proposed Offering of Common Stock
16/04/2018
CRESTWOOD, Ky. and WALTHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]
Boston Marathon Athlete Attempting to Break the Guinness World Record for the Fastest Marathon Ever Run Backwards Finishes Race in 5 Hours, 43 Minutes, 59 Seconds
16/04/2018
BOSTON, April 16, 2018 (GLOBE NEWSWIRE) -- Los Angeles native and Disney movie production lawyer, Loren Zitomersky (aka “The Backwards Guy”), attempted to break the Guinness World Record for the fastest marathon ever [...]
Advanced Proteome Therapeutics Announces Appointment of New Board Members
16/04/2018
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of Dr. John R. Garrett [...]
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock
16/04/2018
HOUSTON, April 16, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and [...]
Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results
16/04/2018
SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, [...]
HTG Promotes John Lubniewski to President and Chief Operating Officer
16/04/2018
Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz., April 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments [...]
Mateon Therapeutics Raises Net Proceeds of Approximately $2.4 Million in Financing Transaction
16/04/2018
SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, [...]
IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors
16/04/2018
MOUNTAIN VIEW, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today announced the appointment of Maria Sainz and David Bruce to the Company’s Board of Directors effective as of April 13, [...]
Novavax Announces Closing of Public Offering
16/04/2018
GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced the [...]
Microbot Medical Exercises Option to Acquire Novel Technology from CardioSert Ltd.
16/04/2018
Expands Intellectual Property (IP) Portfolio, Addressable Markets and Barriers of Entry HINGHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in [...]
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
16/04/2018
-Off-the-shelf CAR-T candidates against BCMA and CD70 address both hematologic malignancies and solid tumors - -New data demonstrate high editing rates, consistent expression, selective and potent cell killing- ZUG, [...]
Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders
16/04/2018
REDWOOD CITY, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced that it has awarded three research grants to supplement institutional funding for nephrology and/or [...]
Hydropothecary Announces Stock Option Grants to Officers and Employees
16/04/2018
GATINEAU, Quebec, April 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE:THCX) announces that it has made a grant of stock options under its stock option plan to certain [...]
Hydropothecary annonce l'octroi d'options d'achat d'actions à ses dirigeants et employés
16/04/2018
GATINEAU, Québec, 16 avr. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE:THCX) annonce qu'en vertu de son régime d'options d'achat d'actions, elle a accordé des options d [...]
News Release: Essilor to put proven expertise of vision care capacity-building at the service of the Commonwealth
16/04/2018
Essilor to put proven expertise of vision care capacity-building at the service of the Commonwealth PDF Version of the news release (Charenton-le-Pont, France, 16 April 2018) - Essilor commits to expanding its award [...]
Communiqué : Essilor met son expertise de l'économie inclusive au service de la santé visuelle dans le Commonwealth
16/04/2018
Essilor met son expertise de l'économie inclusive au service de la santé visuelle dans le Commonwealth Version PDF du communiqué (Charenton-le-Pont, France, 16 avril 2018) - Essilor s'engage à étendre ses modèles d' [...]
Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck
16/04/2018
BERKELEY, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced data from its ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist, in [...]
Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy
16/04/2018
Heidelberg, Germany, April 16, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today presented a poster [...]
Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting
16/04/2018
- Preclinical testing raises no safety concerns for MAGE A4 - - Refined preclinical testing strategy expected to further mitigate risk of unexpected off-target toxicity - PHILADELPHIA, Pa. and OXFORD, United Kingdom, [...]

Pages